Swissmedic informs about Control Campaign against illegal Trading in Medicinal Products
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The flourishing illegal online trade in medicinal products poses a serious threat: it not only endangers the health of consumers but also undermines the safety and regulation of the pharmaceutical supply chain. To address this issue, Swissmedic, the Federal Office for Customs and Border Security (FOCBS) and Swiss Sport Integrity (SSI) participated in an international campaign, coordinated with Europol, to inspect over 1,000 suspicious postal shipments.
According to a Swissmedic press release dated 18 December 2024, approximately one-quarter of the inspected shipments contained illegal medicinal products or doping agents. A total of 246 packages were seized, containing products such as erectile stimulants and narcotics. Over 90% of the confiscated items originated from India, often shipped through concealed routes.
These findings highlight the critical importance of international cooperation in combating the illegal trade in medicinal products. At the same time, they draw attention to the significant health risks and the support of criminal networks associated with the purchase of such products.
The insights gained from the inspections have been shared with Europol to further intensify international efforts against the illegal trade and to strengthen the safety of the pharmaceutical supply chain.
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


